Stempeutics out licenses its stem cell product to Cipla for treating Diabetic Foot Ulcer EP News Bureau Sep 16, 2019 Under this agreement, Cipla will get the exclusive marketing rights for five years in India for DFU product with Stempeutics…
Stempeutics receives Japan process patent for its stem cell drug ‘Stempeucel’ Usha Sharma Jun 8, 2015 Stempeucel is derived from allogeneic pooled mesenchymal stromal cells extracted from the bone marrow of healthy, adult voluntary…
Stempeutics receives ATMP classification from EMA for its novel stem cell drug Stempeucel Usha Sharma Mar 23, 2015 The first stem cell drug-based on pooling technology to be granted ATMP classification Stempeutics Research, a group company of…
